Envoy Medical (NASDAQ:COCH) versus Lifeward (NASDAQ:LFWD) Financial Analysis

Envoy Medical (NASDAQ:COCH) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Valuation and Earnings

This table compares Envoy Medical and Lifeward”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240,000.00	228.38	-$23.76 million	($4.60)	-1.54
Lifeward	$22.03 million	0.76	-$19.91 million	($16.82)	-0.35

Lifeward has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 7.2% of Envoy Medical shares are held by company insiders. Comparatively, 1.1% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Envoy Medical and Lifeward, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	2	0	2.25
Lifeward	1	1	2	0	2.25

Envoy Medical currently has a consensus target price of $21.00, indicating a potential upside of 195.77%. Lifeward has a consensus target price of $10.00, indicating a potential upside of 68.35%. Given Envoy Medical’s higher probable upside, equities research analysts plainly believe Envoy Medical is more favorable than Lifeward.

Volatility & Risk

Envoy Medical has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

Profitability

This table compares Envoy Medical and Lifeward’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
Lifeward	-141.28%	-235.86%	-81.72%

Summary

Envoy Medical beats Lifeward on 6 of the 11 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.